InsidersTradesSigma
Total declarations
Company
▲ Purchases (0 ops.)
▼ Sales (0 ops.)
Insider track record
OtherDisclosed buys
0
Disclosed sells
0
T+90 hit rate
0%
T+90 mean return
-22.8%
Across 1 buy signal with a settled T+90 return. Return basis: close on the day after publication.
Signal history
Browse the detailed record of transactions filed by Hogge Gary S., Officier. Officer active across 1 company, notably Lineage Cell Therapeutics, Inc.. Aggregated, 2 reports have been published. History available since 28 December 2021. The latest transaction was filed on 28 December 2021 (Levée d'options). Regulator: SEC (Form 4). The full history is openly available.
Companies and markets linked to Hogge Gary S.
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
Declarations2 total
13,020 sharesCommon Shares, no par valueSEC:0001493152-23-004895:0
185,000 shares@ US$0.69190.028% mcap50.0% of flowCommon Shares, no par valueSEC:0001493152-21-032897:0
2 of 2 declarations
About Hogge Gary S.
Gary S. Hogge is Senior Vice President of Clinical and Medical Affairs at Lineage Cell Therapeutics, Inc. He is responsible for the strategic direction of the company's clinical and medical initiatives. Hogge plays a key role in optimizing processes and improving clinical outcomes. His expertise in regenerative medicine is an asset for Lineage.
